Stock CLXT CALYXTPAR
Add to a list
To use this feature you must be a member
Log inSign up

Consensus CALYXTPAR

Equities

CLXT

US13173L2060

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-02-04 pm EST 		5-day change 1st Jan Change
17.59 USD -.--% Intraday chart for CALYXTPAR +2.93% -10.44%
Mar. 21 Cibus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 21 Transcript : Cibus, Inc., Q4 2023 Earnings Call, Mar 21, 2024

Evolution of the average Target Price on CALYXTPAR

Price target over the last 5 years

History of analyst recommendation changes

512be651bc2e829d9a968a81.V3QMTfgKDvt6c7jfDWhkmUdLGtS7PVXK1-z0rzIqFGQ.GTZfeoxhWIM9RtmeaRoK6SgCX63jcGz6766cn0IZXlUBJU0AlmtIvxxF8Q~794827a903c2fa863b01c7d2479c6299

Analyst Recommendations on CALYXTPAR

HC Wainwright Downgrades Calyxt to Neutral From Buy MT
ETF Preview: ETFs Mixed, Futures Slightly Higher Pre-Bell After Fed Rate Increase, Jobless Claims MT
Canaccord Genuity Adjusts Calyxt's Price Target to $4 From $6, Keeps Buy Rating MT
Roth Capital Starts Calyxt at Buy With $10 Price Target MT
CALYXT : Berenberg Bank Initiates Coverage on Calyxt With Buy Rating, $9 Price Target MT
CALYXT : HC Wainwright Starts Calyxt at Buy With $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
15.84 USD
Average target price
23 USD
Spread / Average Target
+45.20%
High Price Target
25 USD
Spread / Highest target
+57.83%
Low Price Target
19 USD
Spread / Lowest Target
+19.95%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CALYXTPAR

HC Wainwright
Canaccord Genuity
Roth Capital Partners

Ratings for CALYXTPAR

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CLXT Stock
  4. Consensus CALYXTPAR